- Report
- July 2026
- 191 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- June 2026
- 192 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- August 2026
- 216 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- August 2026
- 351 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- May 2026
- 180 Pages
Global
From €4032EUR$4,500USD£3,454GBP
- Report
- November 2025
- 185 Pages
Global
From €4032EUR$4,500USD£3,454GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2688EUR$3,000USD£2,303GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- January 2026
- 240 Pages
Global
From €3136EUR$3,500USD£2,686GBP
- Report
- April 2026
- 160 Pages
Global
From €2975EUR$3,320USD£2,548GBP
€3718EUR$4,150USD£3,185GBP
- Report
- March 2026
- 140 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- July 2026
- 186 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- July 2026
- 195 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- July 2026
- 183 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- May 2026
- 150 Pages
Global
From €2418EUR$2,699USD£2,071GBP
- Report
- May 2026
- 150 Pages
Global
From €2418EUR$2,699USD£2,071GBP
- Report
- May 2026
- 301 Pages
Global
From €2240EUR$2,500USD£1,919GBP
- Report
- January 2026
- 20 Pages
Global
From €16124EUR$17,995USD£13,811GBP
- Report
- January 2026
- 120 Pages
Global
From €16124EUR$17,995USD£13,811GBP

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more